Antiphospholipid antibodies and subclinical interstitial lung disease in the MESA cohort
Antiphospholipid antibodies are associated with HAA, a quantitative measure of lung injury, inflammation and fibrosis.
Authors
- John S. Kim (ORCID: https://orcid.org/0000-0002-8887-150X)
- Mary Salvatore (ORCID: https://orcid.org/0000-0002-1429-5749)
- Jubal R. Watts (ORCID: https://orcid.org/0000-0002-9006-1637)
- Eric A. Hoffman (ORCID: https://orcid.org/0000-0001-8456-9437)
- John D. Newell (ORCID: https://orcid.org/0000-0002-7337-5001)
- Sushilkumar K. Sonavane (ORCID: https://orcid.org/0000-0001-8823-7261)
- Anna J. Podolanczuk (ORCID: https://orcid.org/0000-0002-9559-1485)
- Claire McGroder (ORCID: https://orcid.org/0000-0003-1157-4627)
- Christine Kim Garcia (ORCID: https://orcid.org/0000-0002-0771-1249)
- Elana J. Bernstein (ORCID: https://orcid.org/0000-0001-5560-6390)
- R. Graham Barr (ORCID: https://orcid.org/0000-0001-8021-0072)
- P. H. Nath
- Ganesh Raghu
Institutions
- University of Iowa (US)
- Albert Einstein College of Medicine (US)
- University of Washington (US)
- Cornell University (US)
- Columbia University Irving Medical Center (US)
- Jacksonville College (US)
- University of Alabama at Birmingham (US)
- Mayo Clinic in Florida (US)
- University of Virginia (US)
Publication Details
- Journal
- Respiratory Research
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1186/s12931-025-03395-3
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Bristol-Myers Squibb
- Pulmonary Fibrosis Foundation
- Gilead Sciences
- FibroGen
- COPD Foundation
- Regeneron Pharmaceuticals
- Veracyte
- Siemens Healthineers
- National Institutes of Health
- Genentech
- National Heart, Lung, and Blood Institute